Markers of hypercoagulability and risk of death and rehospitalization in heart failure patients: a pilot study on the effects of Fondaparinux To evaluate the effects of fondaparinux on biochemical parameters and clinical events according to different duration of treatment in heart failure patients (III-IV NYHA). Primary end-point: circulat...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

remifentanil efficacy in labor Efficacia del remifentanil nel traviglio di parto To compare analgesic efficacy of continuous vs intermittent administration of remifentanil at the end of the first hour of labor Confrontare l’efficacia analgesica della somministrazione continu...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

EFFECT OF FSH TREATMENT ON ANEUPLOIDIC RATE IN OLIGOASTENOZOOSPERMIC PATIENTS decrease of aneuploidic rate by treatment

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

Pharmacokinetic evaluation of a new formulation of recombinant factor IX (BeneFIX) in the italian population with severe or moderate B haemophilia previously treated Primary endpoint of the study will be the evaluation of the variability of pharmacokinetic parameters (in vivo recovery, AUC, clearance, MRT, terminal half life, Cmax, elimination k, volume of distrib...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

A SINGLE-CENTRE, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY TO ASSESS SAFETY AND EFFICACY OF COMBINATION THERAPY WITH VARDENAFIL 10 mg AND TAMSULOSIN 0,4 mg IN THE TREATMENT OF MEN WITH PERSISTENT IRRITATIVE URINARY SYMPTOMS SAFETY AND EFFICACY OF VARDENAFIL 10 MG IN PATIENTS WITH IRRITATIVE URINARY SYMPTOMS

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

LONG-TERM OXYGEN THERAPY (LTOT) IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) PATIENTS WITH MODERATE CHRONIC HYPOXEMIA AND CHRONIC HEART FAILURE The main goal of the study is to investigate whether, in COPD patients with chronic heart failure and moderate chronic hypoxemia (55 < PaO2 < 65 mmHg), the appropriate medical treatment without LTOT ...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

open, non comparative, prospectic, phase IV clinical study to evaluate the activity and tolerance of Cinacalcet-HCl (drug name Mimpara) in patients affected by MEN1-associated primary hyperparathyroidism To study the activities of Cinacalcet- HCl administered to patients with MEN1-associated primary hyperparathyroidism (plasma PTH> 7.6 pmol / ml or 70 pg / ml and total serum calcium> 10.3 mg / dl or 2...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

RANDOMIZED MULTICENTER STUDY ON DALTEPARIN TREATMENT IN IVF PATIENTS DALTEPARIN TREATMENT INCREASES IMPLANTATION RATE

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

18F-Fluorometilcholine (18F-FCH) PET/CT sensibility in diagnosing breast cancer metastasis sensibilita' della 18F-Fluorometilcolina (18F-FCH) PET/CT nella diagnosi delle metastasi del cancro mammario evaluation of 18F-FCH PET/CT for diagnosis of de novo breast cancer metastasis valutazione della sensibilità diagnostica della PET/CT eseguita con tracciante 18F-FCH nella diagnosi della recidi...

• Pays Aucun
• Organes Aucun
• Spécialités Aucune

evalutation of the antitussive effect of Erdosteine in patients with chronic bronchitis Valutazione dell'effetto protettivo verso la tosse esercitato dall'assunzione di Erdosteina nei pazienti con bronchite cronica evaluation of the anti-tussive activity of Erdostein Valutazione dell'effetto antitossivo dell'Erdosteina

• Pays Aucun
• Organes Aucun
• Spécialités Aucune